Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

The time course of attentional bias to cues of threat and safety.

Schmidt LJ, Belopolsky AV, Theeuwes J.

Cogn Emot. 2017 Aug;31(5):845-857. doi: 10.1080/02699931.2016.1169998. Epub 2016 Apr 6.

PMID:
27050428
2.

Potential threat attracts attention and interferes with voluntary saccades.

Schmidt LJ, Belopolsky AV, Theeuwes J.

Emotion. 2015 Jun;15(3):329-38. doi: 10.1037/emo0000041. Epub 2014 Dec 22.

PMID:
25527964
3.

The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells.

Lu J, Lonergan PE, Nacusi LP, Wang L, Schmidt LJ, Sun Z, Van der Steen T, Boorjian SA, Kosari F, Vasmatzis G, Klee GG, Balk SP, Huang H, Wang C, Tindall DJ.

J Urol. 2015 Feb;193(2):690-8. doi: 10.1016/j.juro.2014.08.043. Epub 2014 Aug 14.

4.
5.

Attentional capture by signals of threat.

Schmidt LJ, Belopolsky AV, Theeuwes J.

Cogn Emot. 2015;29(4):687-94. doi: 10.1080/02699931.2014.924484. Epub 2014 Jun 5.

PMID:
24899117
6.

A systematic review and meta-analysis of the efficacy of lixisenatide in the treatment of patients with type 2 diabetes.

Schmidt LJ, Habacher W, Augustin T, Krahulec E, Semlitsch T.

Diabetes Obes Metab. 2014 Sep;16(9):769-79. doi: 10.1111/dom.12269. Epub 2014 Feb 24. Review.

PMID:
24476092
7.

Determination of antimycin-A in water by liquid chromatographic/mass spectrometry: single-laboratory validation.

Bernardy JA, Hubert TD, Ogorek JM, Schmidt LJ.

J AOAC Int. 2013 Mar-Apr;96(2):413-21.

PMID:
23767368
8.

Androgen receptor: past, present and future.

Schmidt LJ, Tindall DJ.

Curr Drug Targets. 2013 Apr;14(4):401-7.

PMID:
23565753
9.

[Chronic pain. Overview of out-patient pain treatment in Austria].

Krahulec E, Schmidt LJ, Habacher W, Kratzer H.

Schmerz. 2012 Dec;26(6):715-20. doi: 10.1007/s00482-012-1234-5. German.

PMID:
23052968
10.

RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.

Schmidt LJ, Duncan K, Yadav N, Regan KM, Verone AR, Lohse CM, Pop EA, Attwood K, Wilding G, Mohler JL, Sebo TJ, Tindall DJ, Heemers HV.

Mol Endocrinol. 2012 May;26(5):716-35. doi: 10.1210/me.2011-1130. Epub 2012 Mar 28.

11.

Identification of a clinically relevant androgen-dependent gene signature in prostate cancer.

Heemers HV, Schmidt LJ, Sun Z, Regan KM, Anderson SK, Duncan K, Wang D, Liu S, Ballman KV, Tindall DJ.

Cancer Res. 2011 Mar 1;71(5):1978-88. doi: 10.1158/0008-5472.CAN-10-2512. Epub 2011 Feb 15.

12.

Steroid 5 α-reductase inhibitors targeting BPH and prostate cancer.

Schmidt LJ, Tindall DJ.

J Steroid Biochem Mol Biol. 2011 May;125(1-2):32-8. doi: 10.1016/j.jsbmb.2010.09.003. Epub 2010 Sep 29. Review.

PMID:
20883781
13.

Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells.

Heemers HV, Schmidt LJ, Kidd E, Raclaw KA, Regan KM, Tindall DJ.

Prostate. 2010 Jun 15;70(9):959-70. doi: 10.1002/pros.21130.

14.

Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression.

Wang D, Montgomery RB, Schmidt LJ, Mostaghel EA, Huang H, Nelson PS, Tindall DJ.

Cancer Res. 2009 Dec 15;69(24):9448-56. doi: 10.1158/0008-5472.CAN-09-1903.

15.

Optimal pacing strategy: from theoretical modelling to reality in 1500-m speed skating.

Hettinga FJ, De Koning JJ, Schmidt LJ, Wind NA, Macintosh BR, Foster C.

Br J Sports Med. 2011 Jan;45(1):30-5. doi: 10.1136/bjsm.2009.064774. Epub 2009 Oct 22.

PMID:
19850574
16.

Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenografts.

Schmidt LJ, Regan KM, Anderson SK, Sun Z, Ballman KV, Tindall DJ.

Prostate. 2009 Dec 1;69(16):1730-43. doi: 10.1002/pros.21022.

17.

Androgen modulation of coregulator expression in prostate cancer cells.

Heemers HV, Regan KM, Schmidt LJ, Anderson SK, Ballman KV, Tindall DJ.

Mol Endocrinol. 2009 Apr;23(4):572-83. doi: 10.1210/me.2008-0363. Epub 2009 Jan 22.

18.

Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.

Boorjian SA, Heemers HV, Frank I, Farmer SA, Schmidt LJ, Sebo TJ, Tindall DJ.

Endocr Relat Cancer. 2009 Mar;16(1):123-37. doi: 10.1677/ERC-08-0124. Epub 2008 Oct 9.

19.

Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.

Dehm SM, Schmidt LJ, Heemers HV, Vessella RL, Tindall DJ.

Cancer Res. 2008 Jul 1;68(13):5469-77. doi: 10.1158/0008-5472.CAN-08-0594.

20.

Chronic toxicity of hydrogen peroxide to Daphnia magna in a continuous exposure, flow-through test system.

Meinertz JR, Greseth SL, Gaikowski MP, Schmidt LJ.

Sci Total Environ. 2008 Mar 25;392(2-3):225-32. doi: 10.1016/j.scitotenv.2007.12.015.

PMID:
18206212
21.
22.

Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride.

Schmidt LJ, Ballman KV, Tindall DJ.

Prostate. 2007 Jul 1;67(10):1111-20.

PMID:
17477363
23.

Prostate cancer cells use genetic and epigenetic mechanisms for progression to androgen independence.

Murillo H, Schmidt LJ, Karter M, Hafner KA, Kondo Y, Ballman KV, Vasmatzis G, Jenkins RB, Tindall DJ.

Genes Chromosomes Cancer. 2006 Jul;45(7):702-16.

PMID:
16615098
24.
25.
26.
27.

Anterior capsulotomy for treatment of refractory obsessive-compulsive disorder: results in a young and an old patient.

Christensen DD, Laitinen LV, Schmidt LJ, Hariz MI.

Stereotact Funct Neurosurg. 2002;79(3-4):234-44.

PMID:
12890982
28.

p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6.

Debes JD, Schmidt LJ, Huang H, Tindall DJ.

Cancer Res. 2002 Oct 15;62(20):5632-6.

29.

Liquid chromatographic determination of florfenicol in the plasma of multiple species of fish.

Vue C, Schmidt LJ, Stehly GR, Gingerich WH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 15;780(1):111-7.

PMID:
12383486
30.

Child/parent-assessed population health outcome measures: a structured review.

Schmidt LJ, Garratt AM, Fitzpatrick R.

Child Care Health Dev. 2002 May;28(3):227-37. Review.

PMID:
12064288
31.

Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells.

Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ.

Cancer Res. 2002 Feb 15;62(4):1008-13.

32.

Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state.

Murillo H, Huang H, Schmidt LJ, Smith DI, Tindall DJ.

Endocrinology. 2001 Nov;142(11):4795-805.

PMID:
11606446
34.

PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression.

Huang H, Cheville JC, Pan Y, Roche PC, Schmidt LJ, Tindall DJ.

J Biol Chem. 2001 Oct 19;276(42):38830-6. Epub 2001 Aug 8.

35.

Polycyclic aromatic hydrocarbons, aliphatic hydrocarbons, trace elements, and monooxygenase activity in birds nesting on the North Platte River, Casper, Wyoming, USA.

Custer TW, Custer CM, Dickerson K, Allen K, Melancon MJ, Schmidt LJ.

Environ Toxicol Chem. 2001 Mar;20(3):624-31.

PMID:
11349865
36.

Liquid chromatographic determination of para-toluenesulfonamide in edible fillet tissues from three species of fish.

Meinertz JR, Schmidt LJ, Stehly GR, Gingerich WH.

J AOAC Int. 1999 Sep-Oct;82(5):1064-70.

PMID:
10513008
37.

Characterization of a TPA-response element in the 5'-flanking region of the androgen receptor gene.

Kumar MV, Jones EA, Felts SJ, Blexrud MD, Grossmann ME, Blok LJ, Schmidt LJ, Tindall DJ.

J Androl. 1998 Sep-Oct;19(5):595-602.

39.

Activation of a muscle-specific actin gene promoter in serum-stimulated fibroblasts.

Stoflet ES, Schmidt LJ, Elder PK, Korf GM, Foster DN, Strauch AR, Getz MJ.

Mol Biol Cell. 1992 Oct;3(10):1073-83.

40.
41.

Development of a tool to assess suicide risk factors in urban adolescents.

White GL Jr, Murdock RT, Richardson GE, Ellis GD, Schmidt LJ.

Adolescence. 1990 Fall;25(99):655-66.

PMID:
2264514
42.

Negative regulation of serum-responsive enhancer elements.

Subramaniam M, Schmidt LJ, Crutchfield CE 3rd, Getz MJ.

Nature. 1989 Jul 6;340(6228):64-6.

PMID:
2739725
44.

The effects of diphosphonates on alveolar bone loss.

Schmidt LJ, Rowe DJ.

Quintessence Int. 1987 Jul;18(7):497-501. No abstract available.

PMID:
2976952
45.

Specific stimulation of actin gene transcription by epidermal growth factor and cycloheximide.

Elder PK, Schmidt LJ, Ono T, Getz MJ.

Proc Natl Acad Sci U S A. 1984 Dec;81(23):7476-80.

46.

Acute necrotizing ulcerative gingivitis: clinical features, etiology and treatment.

Schmidt LJ, Davis CC.

Dent Hyg (Chic). 1984 Jan;58(1):20-4. No abstract available.

PMID:
6585327
47.
49.

The mentally ill in nursing homes. New back wards in the community.

Schmidt LJ, Reinhardt AM, Kane RL, Olsen DM.

Arch Gen Psychiatry. 1977 Jun;34(6):687-91.

PMID:
326217
50.

Community psychiatry. Changes in psychiatric education for community service.

Schmidt LJ.

J Kans Med Soc. 1971 Mar;72(3):151-3 passim. No abstract available.

PMID:
5545173

Supplemental Content

Loading ...
Support Center